Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Carcinoma, Renal Cell 46Sarcoma 21Neoplasms 18Neoplasm Metastasis 15Ovarian Neoplasms 12Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Recurrence 5Melanoma 5Fallopian Tube Neoplasms 5Thyroid Neoplasms 4Prostatic Neoplasms 4Liposarcoma 4Hemangiosarcoma 4Urinary Bladder Neoplasms 3Solid Tumors 3Lung Neoplasms 3Leiomyosarcoma 3Kidney Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Clear-cell metastatic renal cell carcinoma 3Carcinoma, Ovarian Epithelial 3Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Refractory Solid Tumors 2Neuroendocrine Tumors 2Gliosarcoma 2Financial Stress 2Chondrosarcoma, Extraskeletal Myxoid 2

Interventions

Carboplatin 69Paclitaxel 63Cisplatin 32Topotecan 29Gemcitabine 21Docetaxel 20Cyclophosphamide 18Filgrastim 17liposomal doxorubicin 15Peripheral Blood Stem Cell Transplantation 15Bevacizumab 14sargramostim 11Taxes 10Drug Therapy 10Therapeutics 7Psychiatric Rehabilitation 7Immunohistochemistry 7Erlotinib Hydrochloride 7Amifostine 7Melphalan 6Chemotherapy, Adjuvant 6rucaparib 5pembrolizumab 5mirvetuximab soravtansine 5ixabepilone 5Surgical Procedures, Operative 5Mass Spectrometry 5Interleukin-12 Subunit p35 5Flow Cytometry 5Etoposide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Ovarian Epithelial × pazopanib × Clear all
NCT00281632 2018-09-17

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

GlaxoSmithKline

Phase 2 Completed
35 enrolled 24 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01238770 2016-02-10

Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer

University Hospital Heidelberg

Phase 1/2 Completed
10 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

GlaxoSmithKline

Phase 2 Completed
12 enrolled 6 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡